(24 days)
No
The description focuses on standard immunoassay technology and instrumentation, with no mention of AI or ML.
No.
The device is an in vitro diagnostic device used to verify the calibration range of an immunodiagnostic system for quantitative measurements, not to treat or prevent disease.
No
The device description clearly states its purpose is for "verifying the calibration range of the VITROS Immunodiagnostic System". It is a calibration verification device, not a diagnostic device itself, but rather used to ensure the accuracy of a diagnostic system.
No
The device description clearly outlines a system comprised of reagent packs, calibrators, and instrumentation, indicating a hardware component is essential to its function. It is not solely software.
Yes, this device is an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The "Intended Use / Indications for Use" section explicitly states "For in vitro use". It also describes the device's purpose as verifying the calibration range of a system used for the quantitative measurement of analytes (folate and vitamin B12) in human body fluids (serum, plasma, whole blood). This is a classic description of an in vitro diagnostic device used in a laboratory setting to analyze samples taken from the human body.
- Device Description: The description details a system that uses "luminescence as the signal in the quantitative and semi-quantitative determination of selected analytes in human body fluids". This further reinforces its role in analyzing biological samples outside of the body.
- Components: The components listed (reagent pack, calibrators, instrumentation, common reagents) are typical of an in vitro diagnostic system used for performing assays on biological samples.
The information provided clearly indicates that this device is designed to be used outside of the human body to examine specimens for diagnostic purposes, which is the definition of an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
For in vitro use in verifying the calibration range of the VITROS Immunodiagnostic System when used for the quantitative measurement of folate in human serum, plasma (heparin) and whole blood.
For in vitro use in verifying the calibration range of the VITROS Immunodiagnostic System when used for the quantitative measurement of vitamin B12 in human serum and plasma [EDTA or heparin].
Product codes
JJX
Device Description
The VITROS Immunodiagnostic System uses luminescence as the signal in the quantitative and semi-quantitative determination of selected analytes in human body fluids, commonly serum, plasma and urine. Coated microwells are used as the solid phase separation system.
The system is comprised of three main elements:
- The VITROS Immunodiagnostic Products (in this case VITROS Immunodiagnostic Products Reagent Pack, VITROS Immunodiagnostic Products Calibrators, which are combined by the VITROS Immunodiagnostic System to perform a VITROS assay).
- The VITROS Immunodiagnostic System instrumentation, which provides automated use of the immunoassay kits. The VITROS Immunodiagnostic System was cleared for market by a separate 510(k) pre-market notification (K962919).
- Common reagents used by the VITROS System in each assay. The VITROS Immunodiagnostic Products Signal Reagent and VITROS Immunodiagnostic Products Universal Wash Reagent were cleared as part of the VITROS Immunodiagnostic Products Total T3 510(k) pre-market notification (K964310).
The VITROS System and common reagents are dedicated specifically only for use with the VITROS Immunodiagnostic Products range of immunoassay products.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
The data presented in the pre-market notification demonstrate that the VITROS Folate and Vitamin B12 Range Verifiers are substantially equivalent to the predicate device, for which there is FDA clearance.
Equivalence was demonstrated by comparing the physical properties and intended uses of these devices with commercially available reagents.
The data presented in the premarket notification provide a reasonable assurance that the VITROS Folate and Vitamin B12 Range Verifiers are safe and effective for the stated intended use.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 862.1660 Quality control material (assayed and unassayed).
(a)
Identification. A quality control material (assayed and unassayed) for clinical chemistry is a device intended for medical purposes for use in a test system to estimate test precision and to detect systematic analytical deviations that may arise from reagent or analytical instrument variation. A quality control material (assayed and unassayed) may be used for proficiency testing in interlaboratory surveys. This generic type of device includes controls (assayed and unassayed) for blood gases, electrolytes, enzymes, multianalytes (all kinds), single (specified) analytes, or urinalysis controls.(b)
Classification. Class I (general controls). Except when intended for use in donor screening tests, quality control materials (assayed and unassayed) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.
0
JAN 29 1999
Chapter 1 - Summary Information
510(k) Summary
This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92
The assigned 510(k) number is: 3990034 __
1. Submitter name, address, contact
Ortho-Clinical Diagnostics, Inc. 100 Indigo Creek Drive Rochester, New York 14626-5101 (716) 453-3790
Contact Person: Anne Zavertnik
Date 510(k) prepared: January 4, 1999
2. Device Name
Trade or Proprietary Name: VITROS Immunodiagnostic Products Folate Range Verifiers; VITROS Immunodiagnostic Products Vitamin B12 Range Verifiers.
Common Name: Range Verifiers
Classification Name: VITROS Range verifiers for use in verifying the calibration range of the VITROS Immunodiagnostic System when used for the measurement of immunoassays which include Folate and Vitamin B12.
3. Predicate Device
The VITROS Immunodiagnostic Products Folate and Vitamin B12 Range Verifiers are substantially equivalent to VITROS Immunodiagnostic Products FSH Range Verifiers (K973517).
4. Device Description
The VITROS Immunodiagnostic System uses luminescence as the signal in the quantitative and semi-quantitative determination of selected analytes in human body fluids, commonly serum, plasma and urine. Coated microwells are used as the solid phase separation system.
The system is comprised of three main elements:
-
- The VITROS Immunodiagnostic Products (in this case VITROS Immunodiagnostic Products Reagent Pack, VITROS Immunodiagnostic Products Calibrators, which are combined by the VITROS Immunodiagnostic System to perform a VITROS assay).
Continued on next page
- The VITROS Immunodiagnostic Products (in this case VITROS Immunodiagnostic Products Reagent Pack, VITROS Immunodiagnostic Products Calibrators, which are combined by the VITROS Immunodiagnostic System to perform a VITROS assay).
1
510(k) Summary, Continued.
-
- The VITROS Immunodiagnostic System instrumentation, which provides automated use of the immunoassay kits. The VITROS Immunodiagnostic System was cleared for market by a separate 510(k) pre-market notification (K962919).
-
- Common reagents used by the VITROS System in each assay. The VITROS Immunodiagnostic Products Signal Reagent and VITROS Immunodiagnostic Products Universal Wash Reagent were cleared as part of the VITROS Immunodiagnostic Products Total T3 510(k) pre-market notification (K964310).
The VITROS System and common reagents are dedicated specifically only for use with the VITROS Immunodiagnostic Products range of immunoassay products.
5. Device Intended Use
For in vitro use in verifying the calibration range of the VITROS Immunodiagnostic System when used for the quantitative measurement of folate in human serum, plasma (heparin) and whole blood.
For in vitro use in verifying the calibration range of the VITROS Immunodiagnostic System when used for the quantitative measurement of vitamin B12 in human serum and plasma [EDTA or heparin].
6. Comparison to Predicate Device
The VITROS Immunodiagnostic Products Range Verifiers are substantially equivalent to VITROS FSH Range Verifiers (predicate device), which was approved by FDA (K973517) for IVD use.
Table 1 lists the similarities and differences of the device characteristics between the VITROS Folate Range Verifiers with the predicate device, VITROS FSH Range Verifiers.
Continued on next page
2
510(k) Summary, Continued
Table 1 List of the assay characteristics
| Device
Characteristic | VITROS FOLATE
Range Verifiers | Predicate
Device |
|---------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------|
| Intended use | For use in verifying the
calibration range of the
VITROS
Immunodiagnostic System
when used for the
measurement of a
particular analyte (see page
11 for a list of analytes). | For use in verifying the
calibration range of the
VITROS
Immunodiagnostic
System when used for the
measurement of FSH. |
| Matrix of Range Verifiers | A base matrix of liquid or
freeze-dried human plasma
or buffered matrix spiked
with analyte (see page 11
for full details). | A base matrix of freeze-
dried human plasma
spiked with human
pituitary FSH. |
| Range Verifier levels | Low and high | Low and high |
7. Conclusions
The data presented in the pre-market notification demonstrate that the VITROS Folate and Vitamin B12 Range Verifiers are substantially equivalent to the predicate device, for which there is FDA clearance.
Equivalence was demonstrated by comparing the physical properties and intended uses of these devices with commercially available reagents.
The data presented in the premarket notification provide a reasonable assurance that the VITROS Folate and Vitamin B12 Range Verifiers are safe and effective for the stated intended use.
3
Public Health Service
Image /page/3/Picture/2 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features the department's emblem, which consists of a stylized caduceus-like symbol with three human profiles facing right. The profiles are stacked on top of each other, creating a sense of depth. Encircling the emblem is the text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" in a circular arrangement.
JAN 29 1999
Food and Drug Administration 2098 Gaither Road Rockville MD 20850
Anne Zavertnik Regulatory Affairs Associate Ortho-Clinical Diagnostics Regulatory Affairs MC00882 100 Indigo Creek Drive Rochester, NY 14626-5101
- Re: K990026
Trade Name: VITROS Immunodiagnostic Products Folate Range Verifiers VITROS Immunodiagnostic Products Vitamin B12 Range Verifiers Regulatory Class: I Product Code: JJX Dated: January 4, 1999 Received: January 5, 1999
Dear Ms. Zavertnik:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
4
Page 2
Under the Clinical Laboratory Improvement Amendments of 1988 (CLIA-88), this device may require a CLIA complexity categorization. To determine if it does, you should contact the Centers for Disease Control and Prevention (CDC) at (770)488-7655.
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4588. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll free number (800) 638-2041 or at (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html"
Sincerely yours,
Steven Sutman
Steven I. Gutman, M.D., M.B.A. Director Division of Clinical Laboratory Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
Statement of Intended Use
| 510(k) Number (if known): | K 990026 |
|---|---|
| Device Name: | VITROS Immunodiagnostic Products Range Verifiers |
| Indications for Use: | For in vitro use in verifying the calibration range of the VITROS Immunodiagnostic System when used for the quantitative measurement of folate in human serum, plasma (heparin) and whole blood. |
| For in vitro use in verifying the calibration range of the VITROS Immunodiagnostic System when used for the quantitative measurement of vitamin B12 in human serum and plasma [EDTA or heparin]. |
(Division Sign-Off)
Division of Clinical Laboratory Devices
510(k) Number: K990026
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
.
Concurrence of CDRH, Office of Device Evaluation (ODE)
| Prescription Use
| (Per 21 CFR 801.109) | |
|---|---|
| ------------------------------------------ | --------------------------------------------------------- |
OR
| Over-The-Counter Use
| (Optional Format 1-2-96) | |
|---|---|
| -------------------------------------------------- | -- |